School of Pharmacy, Chengdu Medical College, Chengdu 610500, China; State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.
School of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
J Chromatogr A. 2018 Nov 16;1576:10-18. doi: 10.1016/j.chroma.2018.09.027. Epub 2018 Sep 17.
Although herb medicines have become the major source for new drug discovery, many of them are largely under-explored due to the purity-activity relationship. Efficient identification of bioactive compounds in conventional stepwise separation and isolation has not yet been elucidated. Therefore, we proposed a new separation strategy for holism understanding of herb pharmacology using molecularly imprinted polymers (MIPs). Astragali Radix (AR), important in traditional Chinese medicine, was chosen in this study for multicomponent knockout followed by bioactivity evaluation. We prepared calycosin molecularly imprinted polymers (calycosin-MIPs) which could selectively recognize flavonoid aglycons in AR. The molecular selectivity of calycosin-MIPs as a critical parameter was evaluated using the template and other high content compounds in AR. Based on it, using the calycosin-MIPs material via solid-phase extraction procedures was applied for the knockout of flavonoid aglycons in AR. Finally, hypoxia/reoxygenation model in H9c2 cells was used to evaluate the activity of the AR extract before and after knockout. The results showed that calycosin-MIPs as recognition materials for flavonoid aglycons in AR are applied in one-step separation with high selectivity and tunability. The subextract in the absence of flavonoid aglycons has been demonstrated to clarify the cardio-protective components of AR. In conclusion, this proof-of-principle study is the first one showing that molecular imprinting technology coupled with a bioassay can be used to explore the bioactive variability from the perspective of multicomponent separation of herbal medicine.
虽然草药已成为新药发现的主要来源,但由于纯度-活性关系,其中许多草药仍未得到充分探索。在常规的逐步分离和分离中,尚未阐明有效鉴定生物活性化合物的方法。因此,我们提出了一种使用分子印迹聚合物(MIP)对草药药理学进行整体理解的新分离策略。在这项研究中,选择了中药中的重要成分黄芪(AR)进行多组分敲除,然后进行生物活性评估。我们制备了毛蕊异黄酮分子印迹聚合物(calycosin-MIP),可以选择性地识别 AR 中的黄酮苷元。使用模板和 AR 中的其他高含量化合物评估 calycosin-MIP 作为关键参数的分子选择性。在此基础上,通过固相萃取程序,使用 calycosin-MIP 材料对 AR 中的黄酮苷元进行敲除。最后,使用 H9c2 细胞缺氧/复氧模型评估 AR 提取物在敲除前后的活性。结果表明,calycosin-MIP 作为 AR 中黄酮苷元的识别材料,可用于一步高选择性和可调性分离。在不存在黄酮苷元的亚提取物中,已证明 AR 的心脏保护成分得到了澄清。总之,这项原理验证研究是第一个表明,分子印迹技术与生物测定相结合,可用于从草药多组分分离的角度探索生物活性的可变性。